The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: 0.00 (0.00%)
Spread: 2.00 (0.017%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 12,050.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

GLOBAL MARKETS-Stocks rise into year-end on 2021 recovery hopes

Wed, 30th Dec 2020 12:28

* Wall Street futures up 0.34%, Chicago PMI at 1445 GMT

* World stocks up 14% this year, 70% from March lows

* Euro hits highest since April 2018 vs dollar

*

* Graphic: 2020 asset performance http://tmsnrt.rs/2yaDPgn

* Graphic: World FX rates in 2020 http://tmsnrt.rs/2egbfVh

By Carolyn Cohn

LONDON, Dec 30 (Reuters) - Wall Street was set to open
higher and world stocks edged towards recent record highs on
Wednesday, with investor hopes of a strong economic recovery
next year also pushing the safe-haven dollar to its lowest since
April 2018.

Europe's main markets were heading for a sixth straight
session of gains as AstraZeneca and Oxford
University's coronavirus vaccine became the second to be
approved by Britain, helping the FTSE 100 add 0.1%,
though it stuck below the previous day's nine-month highs.

S&P 500 futures rose 0.34% after U.S. stocks had
retreated from an intraday record high on Tuesday.

Conviction that global monetary authorities will continue to
pump liquidity into the banking system has been underpinning
riskier assets in recent weeks.

"Familiar themes are still in play," said Ned Rumpeltin
European head of currency strategy at TD Securities. "Today is a
day very much of where we've been is where we are."

The U.S. Senate was due on Wednesday to hold a procedural
vote that could pave the way for Congress to override U.S.
President Donald Trump's veto of a key defense bill.

Also on Wednesday, the Chicago Purchasing Managers' Index
data for December at 1445 GMT is forecast to give a reading of
57, according to a Reuters poll, against last month's 58.2.

A new, more transmittable variant of the virus is spreading
rapidly, including to the United States, but European Union
countries have also begun rolling out Pfizer and
BioNTech's vaccine this week.

"The prospect of more rapid and widespread inoculation will
be a shot of confidence to markets as the COVID-19 struggle
intensifies," said Janet Mui, investment director at wealth
manager Brewin Dolphin.

MSCI’s world stocks index rose 0.25% to
within touching distance of the record highs it had set on
Tuesday.

The index is up 14% this year and nearly 70% from its March
lows, boosted by trillions of dollars in global economic
stimulus and expectations that coronavirus vaccines will re-open
locked-down economies.

TRADE DEAL

Away from the virus worries, British lawmakers were set to
vote on the UK-EU trade deal later on Wednesday, a day before a
Brexit transition arrangement expires.

MSCI's gauge of Asia-Pacific shares excluding Japan
rose 1.4% to a record high, led by gains in
Chinese shares and bringing its gains this year to 19%.

Japan's Nikkei share average lost 0.45%, however, on
its last trading day of 2020 after jumping to a 30-year high on
Tuesday.

In currency markets, the dollar's weakness continued. It
dropped again on Wednesday, the first day where settlement of
trades will be in 2021.

The U.S. dollar index fell 0.3% to its lowest since
April 2018. The euro reached its highest since April 2018 at
close to $1.23.

The Australian dollar rose 0.9% to $0.7673, a
two-and-a-half-year high. Sterling rose 0.8% above
$1.36.

Bitcoin jumped to a record $28,599.99, after the
digital currency almost quadrupled in value this year amid
heightened interest from bigger investors.

German 10-year bond yields - which move
inversely to price - ticked up to -0.56%.

Oil gained ground as the dollar weakened, U.S. crude oil
inventories declined and Britain approved a second coronavirus
vaccine, though it was set to end the year about 20% lower.

U.S. West Texas Intermediate crude futures were up
0.94% at $48.45 a barrel. Gold was steady at $1,878
an ounce.

(Editing by Larry King)

More News
Today 07:46

AstraZeneca completes collaboration and investment deal with Cellectis

(Alliance News) - AstraZeneca PLC on Monday said it has completed an equity investment in clinical-stage biotechnology company Cellectis, first announced in November.

Read more
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.